Neos Therapeutics, Inc. – Underwriting Agreement (June 29th, 2017)
Neos Therapeutics, Inc. – First Amendment to Facility Agreement (June 5th, 2017)
FIRST AMENDMENT TO FACILITY AGREEMENT (this Amendment), dated as of June 1, 2017, by and among NEOS THERAPEUTICS, INC., a Delaware corporation (Borrower), NEOS THERAPEUTICS COMMERCIAL, LLC, NEOS THERAPEUTICS BRANDS, LLC, NEOS THERAPEUTICS, LP, PHARMAFAB TEXAS, LLC (COLLECTIVELY, THE Guarantors) DEERFIELD PRIVATE DESIGN FUND III, L.P. (DPDF) and DEERFIELD SPECIAL SITUATIONS FUND, L.P. (DSSF, and together with DPDF collectively referred to as the Lenders and together with the Borrower and the Guarantors, the Parties).
Neos Therapeutics, Inc. – Senior Secured Convertible Note (June 5th, 2017)
THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE SECURITIES ACT), OR ANY STATE SECURITIES LAW. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT, INCLUDING PURSUANT TO RULE 144 OR 144A UNDER THE SECURITIES ACT OR PURSUANT TO A PRIVATE SALE EFFECTED UNDER SECTION 4(a)(7) OF THE SECURITIES ACT OR APPLICABLE FORMAL OR INFORMAL SEC INTERPRETATION OR GUIDANCE, SUCH AS A SO-CALLED 4[(a)](1) AND A HALF SALE. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.
Neos Therapeutics, Inc. – Registration Rights Agreement (June 5th, 2017)
REGISTRATION RIGHTS AGREEMENT (this Agreement), dated as of June 1, 2017, by and among Neos Therapeutics, Inc., a Delaware corporation (the Company), Deerfield Private Design Fund III, L.P. (DPDF) and Deerfield Special Situations Fund, L.P. (DSSF and, together with DPDF, the Original Investors and each individually, an Original Investor).
Neos Therapeutics, Inc. – Underwriting Agreement (February 3rd, 2017)
Neos Therapeutics, Inc. – Facility Agreement (August 12th, 2016)
FACILITY AGREEMENT (this Agreement), dated as of May 11, 2016, between Neos Therapeutics, Inc., a Delaware Corporation (the Borrower), and the lenders set forth on the signature page of this Agreement (together with their successors and permitted assigns, the Lenders and, together with the Borrower, the Parties).
Neos Therapeutics, Inc. – Employment Agreement (May 31st, 2016)
This Employment Agreement (Agreement) is made as of the 26th day of May, 2016, between Neos Therapeutics, a Delaware corporation (the Company), and Juergen A. Martens, Ph.D., EMTM (the Executive).
Ocera Therapeutics – OFFICE LEASE TABLE OF CONTENTS 1. BASIC DEFINITIONS AND PROVISIONS 1 A. Premises 1 B. Term 1 C. Permitted Use: 1 D. Base Rent: 1 E. Rent Payment Address 1 F. Security Deposit 1 G. Business Hours 1 H. Electrical Service 1 I. After Hours HVAC Rate 1 J. Parking 2 K. Notice Addresses 2 I. Broker. 2 2. LEASED PREMISES 2 A. Premises 2 B. Rentable Square Foot Determination 2 C. Common Areas 2 3. TERM 2 A. Commencement and Expiration Dates 2 B. Adjustments to Commencement Date 3 C. Delivery of Possession 3 D. Adjustment of Expiration Date 3 E. Right to Occupy. 3 F. Commencement Agreement 3 4. USE 3 A. (December 1st, 2011)